Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-26-027289
Filing Date
2026-06-04
Accepted
2026-06-04 16:42:48
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 321624
2 EX-5 ex5.htm EX-5 16890
3 EX-23.2 ex23-2.htm EX-23.2 3842
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 25426
5 GRAPHIC forms-3_001.jpg GRAPHIC 4524
6 GRAPHIC ex5_001.jpg GRAPHIC 4478
  Complete submission text file 0001493152-26-027289.txt   503839

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5089
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-296499 | Film No.: 261065626
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)